Sensitive and quantitative detection of cardiac troponin I with upconverting nanoparticle lateral flow test with minimized interference

Measurement of cardiac troponin I (cTnI) should be feasible for point-of-care testing (POCT) to diagnose acute myocardial infarction (AMI). Lateral flow immunoassays (LFIAs) have been long implemented in POCT and clinical settings. However, sensitivity, matrix effect and quantitation in lateral flow...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayoumy, Sherif, Martiskainen, Iida, Heikkilä, Taina, Rautanen, Carita, Hedberg, Pirjo, Hyytiä, Heidi, Wittfooth, Saara, Pettersson, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455528/
https://www.ncbi.nlm.nih.gov/pubmed/34548577
http://dx.doi.org/10.1038/s41598-021-98199-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455528/
https://www.ncbi.nlm.nih.gov/pubmed/34548577
http://dx.doi.org/10.1038/s41598-021-98199-y

Ejemplares similares